Clinical Trials Browser

INDUSTRY × RRx-001 × Thoracic × Clear all

NCT02489903 2025-03-17

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Phase 2 Completed

139 enrolled 14 charts

EndocrineGynecologicNETThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT05566041 2024-10-31

REPLATINUM

Phase 3 Active not recruiting

Small Cell Lung Carcinoma

NCT03699956 2024-03-26

REPLATINUM

Phase 3 Terminated

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma